Decrease in Erythrocyte:Plasma lithium ratio by concurrent administration of psychotropic drugs and lithium in mice

General Pharmacology

Volumn 31, Issue 1, 1998, Pages 63-66

  Sadeghipour Roudsari, H R ^a   Farahani, M ^a   Shokrgozar, A ^a   Farsam, H ^a   Dehpour, A R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lithium; Lithium ratio; Psychotropic drugs

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ERYTHROCYTE LEVEL; DRUG TRANSPORT; MALE; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; ANTIPSYCHOTIC AGENTS; CARBAMAZEPINE; CHLORPROMAZINE; DRUG THERAPY, COMBINATION; ERYTHROCYTES; HALOPERIDOL; IMIPRAMINE; LITHIUM; MALE; MICE; PROSPECTIVE STUDIES;

EID: 0032125665     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00428-X     Document Type: Article

References (39)

1. Azizabadi-Farahani M., Mirazi N., Azar M., Farsam H., Dehpour A.R. The effect of concomitant use of neuroleptic drugs and lithium on erythrocyte/plasma lithium ratio in Iranian patients with bipolar disorder. J. Clin. Pharm. Ther. 21:1996;3-7.
2. Bachus S.E., Gale K. Differential effects of chronic treatment with chlorpromazine versus cocaine on behavioral responsiveness to nigra GABA receptor stimulation. Psychopharmacology. 95:1988;56-62.
3. Baldessarini R.J. Drugs and treatment of psychiatric disorders. psychosis and anxiety Hardman J.G., Lambert L.E., Molinoff P.B., Ruddo R.W., Goodman Gilman A. The Pharmacological Basis of Therapeutics. 1996;431-459 McGraw-Hill, New York.
4. Barros H.M.T., Leite J.R. The effect of carbamazepine on two animal models of depression. Psychopharmacology. 92:1987;340-342.
5. Casper R.C., Pandey G., Gosenfeld L., Daris J.M. Intracellular lithium and clinical response. Lancet. 2:1976;418-419.
6. Dehpour A.R., Farsam H., Azizabadi-Farahani M. The effect of lithium on morphine-induced analgesia in mice. Gen. Pharmac. 25:1994;1635-1641.
7. Dehpour A.R., Farsam H., Azizabadi-Farahani M. Inhibition of the morphine withdrawal syndrome and the development of physical dependence on lithium in mice. Neuropharmacology. 34:1995;115-121.
8. Elizur A., Yeret A., Segal Z., Graff E. Lithium and electrolytes plasma/RBC ratio and paradoxical lithium neurotoxicity. Prog. Neuro-Psychopharmac. Biol. Psychiatry. 6:1982;235-241.
9. Flemenbaum A., Weddige R., Miller J. Lithium erythrocyte/plasma ratio as a predictor of response. Am. J. Psychiatry. 135:1978;336-338.
10. Frazer A., Mendels J., Secunda S.K., Cochrane C.M., Bianchi C.P. The prediction of brain lithium concentrations from plasma or erythrocyte measures. J. Psychiat. Res. 10:1973;1-7.
11. Frazer A., Gottlieb J., Mendels J. Lithium ratio and clinical response in manic-depressive illness. Lancet. 1:1977;41-42.
12. Ghadirian A.M., Nair N.P.V., Schwartz G. Effect of lithium and neuroleptic combination on lithium transport, blood pressure, and weight in bipolar patients. Biol. Psychiatry. 26:1989;139-144.
13. Haas M., Schooler J., Tosteson D.C. Coupling of lithium to sodium transport in human red cells. Nature. 258:1975;425-427.
14. Hannaert P.A., Garay R.P. A kinetic analysis of Na-L countertransport in human red blood cells. J. Gen. Physiol. 87:1986;353-368.
15. Hewick D.S., Murray N. Red-blood-cell levels and lithium toxicity. Lancet. 2:1976;473.
16. Kinon B.J., Merson D., Kane J.M. Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat. Psychopharmacology. 84:1984;347-351.
17. Mendels J., Frazer A. Intracellular lithium concentration and clinical response. towards a membrane theory of depression J. Psychiat. Res. 10:1973;9-18.
18. Mendels J., Frazer A., Baron J., Kukopulos A., Reginaldi D., Tondo L., Caliari B. Intraerythrocyte lithium ion concentration and long term maintenance treatment. Lancet. 1:1976;966.
19. Olaisen B., Oye I. Interaction of membrane stabilizing drugs affecting human erythrocytes in vitro. Eur. J. Pharmac. 22:1973;112-116.
20. Pandey G.N., Goel I., Davis J.M. Effect of neuroleptic drugs on lithium uptake by the human erythrocyte. Clin. Pharmac. Ther. 26:1979;96-102.
21. Post R.M., Uhde T.W., Rubinow D.R., Ballenger J.C., Gold P.W. Biochemical effects of carbamazepine. relationship to its mechanisms of action in affective illness Prog. Neuro-Psychopharmac. Biol. Psychiatry. 7:1983;263-271.
22. Post R.M., Leverich G.S., Rosoff A.S., Altshuler L.L. Carbamazepine prophylaxis in refactory affective disorders. a focus on long term follow-up J. Clin. Psychopharmac. 10:1990;318-327.
23. Prien R.F., Kupper D.J., Mansky P.A., Small J.G., Tuason V.B., Voss C.B., Johnson W.E. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. report of the NIGH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination Arch. Gen. Psychiatry. 41:1984;1096-1104.
24. Rowan M.J., O'Connor J.J., Anwyl R. Changes in auditory evoked responses and in the inhibitory action of 5-hydroxytryptophan following chronic treatment with imipramine in the rat. Psychopharmacology. 96:1988;408-413.
25. Ryan W.G., Richards J.M., Lee J.Y. Characteristics of the in vivo RBC:plasma lithium ratio in a clinical setting. Biol. Psychiatry. 26:1989;537-540.
26. Rybakowski J.K. Lithium in erythrocytes. pathogenetic and clinical significance Lithium. 1:1990;75-85.
27. Schou M. Lithium in psychiatric therapy and prophylaxis. J. Psychiat. Res. 6:1968;67-95.
28. Schweyen D.H., Sporka M.C., Burnakis T.G. Evaluation of serum lithium concentration determinations. Am. J. Hosp. Pharm. 48:1991;1536-1537.
29. Seeman P. II. Erythrocyte membrane stabilization by local anesthetics and tranquilizers. Biochem. Pharmac. 15:1966;1753-1766. a.
30. Seeman P.M. Membrane stabilization by drugs. tranquilizers, steroids and anesthetics Int. Rev. Neurobiol. 9:1966;145-221. b.
31. Seeman P.M., Bialy H.S. The surface activity of tranquilizers. Biochem. Pharmac. 12:1963;1181-1191.
32. Seeman P., Weinstein J. I. Erythrocyte membrane stabilization by tranquilizers and antihistamines. Biochem. Pharmac. 15:1966;1737-1752.
33. Smith D.F. Locomotor activity and plasma, red blood cell and cerebral cortex lithium concentration in inbred mice given lithium carbonate. Pharmac. Biochem. Behav. 5:1976;379-382.
34. Spirtes M.A. Lithium levels in monkey and human brain after chronic, therapeutic, oral dosage. Pharmac. Biochem. Behav. 5:1976;143-147.
35. Summerton A.M., Harvey N.S., Forrest A.R.W. New direct method for measuring red cell lithium. J. Clin. Pathol. 42:1989;435-437.
36. Szentistvanyi I., Janka Z. Correlation between the lithium ratio and Na-dependent Li transport of red blood cell during lithium prophylaxis. Biol. Psychiatry. 14:1979;973-977.
37. Upadhyaya A.K., Varma V.K., Sankaranarayanan A., Goel A. Lithium in prophylactic therapy of manic-depressive illness. biochemical correlates of response Biol. Psychiatry. 20:1985;202-205.
38. Vestergaard P. Treatment and prevention of mania. a Scandinavian perspective Neuropsychopharmacology. 7:1992;249-259.
39. Von Knorring L., Smigan L., Perris C., Oreland L. Lithium and neuroleptic drugs in combination. effect on lithium RBC plasma ratio Int. Pharmac. Psychiatry. 17:1982;287-292.